Delivery Order SPE2DB22D1106-SPE2DB25FEEH0

Award Date 3/21/25
Potential Completion Date 3/24/25
Potential Value $8.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $16,317.23, is for the delivery of Fingolimod 0.5 mg capsules. It is a firm fixed-price delivery order contract with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,898.12 Firm Fixed Price Delivery Order contract is for the supply of FINGOLIMOD 0.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of December 5, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $53,304.56, is for the supply of Fingolimod 0.5 mg capsules to support military treatment facilities and federal healthcare programs. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other agencies, collectively valued at up to $999,999,999, that allow the government to efficiently...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Fingolimod 0.5 mg capsules. The contract has a firm fixed price of $13,261.27 and an ultimate completion date of August 5, 2024. It is not a set-aside contract. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $40,485.98, is for the delivery of FINGOLIMOD 0.5 MG CAPSULE 30S, a prescription medication, with a completion date of November 13, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $40,817.40 firm-fixed-price contract is for the supply of FINGOLIMOD 0.5 MG CAPSULE 30S, a medication used to treat certain medical conditions. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,906.06, is for the delivery of FINGOLIMOD 0.5 MG CAPSULE 30S, a prescription medication. The contract is a firm fixed-price delivery order with an ultimate completion date of January 28, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4564377288 units of Fingolimod 0.5 mg capsules. The contract, valued at $33,275.45, was awarded on April 23, 2024 by the Defense Logistics Agency Troop Support Medical, with a completion date of April 24, 2024. This is a firm fixed-price delivery order contract, and there is no set-aside designation mentioned. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is for the delivery of Fingolimod 0.5 mg capsules. The contract, valued at $12,806.49, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, worth up to $999,999,999 through November 2026. This IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $190,846.71, is for the delivery of FINGOLIMOD 0.5 MG CAPSULE 30S, a specialty medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of April 26, 2023. The contract has no set-aside designation, indicating open competition. AmerisourceBergen...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEEH0
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,053.12 firm fixed-price contract is for the delivery of the drug Fingolimod 0.5 mg capsules, with a period of performance through March 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract also has a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

The contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and there is no information provided on any major subcontractors.

Generated 6/21/25, 9:52 AM